share_log

Truist Securities Maintains Buy on Autolus Therapeutics, Raises Price Target to $11

Truist Securities Maintains Buy on Autolus Therapeutics, Raises Price Target to $11

Truist Securities维持对Autolus Therapeutics的买入,将目标股价上调至11美元
Moomoo 24/7 ·  04/09 13:41

Truist Securities analyst Gil Blum maintains Autolus Therapeutics (NASDAQ:AUTL) with a Buy and raises the price target from $10 to $11.

Truist Securities分析师吉尔·布鲁姆维持Autolus Therapeutics(纳斯达克股票代码:AUTL)的买入并将目标股价从10美元上调至11美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发